Maestros Electronics Telecommun Systems Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Maestros Electronics & Telecommun. Systems Ltd is ₹ 77.7 as of 23 Oct 15:30 . The P/E Ratio of Maestros Electronics & Telecommun. Systems Ltd changed from 12.2 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 44.3 on March 2024 to 35.3 on March 2023 . This represents a CAGR of -3.71% over 6 years The Market Cap of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 60.31 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 3135 crore on March 2024 to ₹ 2274 crore on March 2023 . This represents a CAGR of -5.21% over 6 years The revenue of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 10.61 crore as compare to the Mar '26 revenue of ₹ 12.81 crore. This represent the decline of -17.17% The revenue of Thyrocare Technologies Ltd for the Jun '26 is ₹ 244.88 crore as compare to the Mar '26 revenue of ₹ 228.84 crore. This represent the growth of 7.01% The ebitda of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 2.4 crore as compare to the Mar '26 ebitda of ₹ 3.13 crore. This represent the decline of -23.32% The ebitda of Thyrocare Technologies Ltd for the Jun '26 is ₹ 82.13 crore as compare to the Mar '26 ebitda of ₹ 79.98 crore. This represent the growth of 2.69% The net profit of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 1.25 crore to ₹ 1.67 crore over 9 quarters. This represents a CAGR of 13.74% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 51.33 crore over 9 quarters. This represents a CAGR of 40.35% The Dividend Payout of Maestros Electronics & Telecommun. Systems Ltd changed from 22.04 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .

About Maestros Electronics & Telecommun. Systems Ltd

Maestros Electronics & Telecommunications Systems Limited was incorporated on February 19, 2010.
At present, Company is engaged in activities pertaining to design, development, and manufacturing of creating products and services for financial inclusion, cardiology, gynecology, critical care patient and diseases management in medicine with rich experience in latest technologies and communication. It provide an advanced portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems and much more. With state-of-the-art R&D and manufacturing facilities located in Mumbai, India, Company excel in creating cutting-edge solutions tailored to the needs of clients.
It mainly operates into two segments viz, Electronics & Instrumentation (E&T) and Telemedicine.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Maestros Electronics & Telecommun. Systems Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Maestros Electronics & Telecommun. Systems Ltd or Thyrocare Technologies Ltd?

Market cap of Maestros Electronics & Telecommun. Systems Ltd is 85 Cr while Market cap of Thyrocare Technologies Ltd is 7,357 Cr

What are the key factors driving the stock performance of Maestros Electronics & Telecommun. Systems Ltd and Thyrocare Technologies Ltd?

The stock performance of Maestros Electronics & Telecommun. Systems Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Maestros Electronics & Telecommun. Systems Ltd and Thyrocare Technologies Ltd?

As of October 24, 2026, the Maestros Electronics & Telecommun. Systems Ltd stock price is INR ₹77.7. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹462.25.

How do dividend payouts of Maestros Electronics & Telecommun. Systems Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Maestros Electronics & Telecommun. Systems Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.